Efficacy of autologous platelet rich plasma (PRP) in prevention of hypertrophic scar

Evaluation the efficacy of autologous platelet rich plasma (PRP) in prevention of hypertrophic scar at the site of sternotomy in adults with open heart surgery in Shahid Modarres Hospital in 2020-2021

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201007048955N1

Enrollment

Registered

2020-10-11

Start date

2020-11-21

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid and hypertrophic scar.

Interventions

Intervention group: Before the surgery and injection of anesthetics and anticoagulants, a certain volume of blood is taken from the patient .PRP is prepared by an educated person with the help of a s

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Not having diabetes Not having autoimmune diseases Not having thrombocytopenia(platelets below 150000) Not receiving glucocorticoids

Exclusion criteria

Exclusion criteria: Patient not referring to the doctor for surveillance Death of the patient during the surveillance period

Design outcomes

Primary

Measure	Time frame
Hypertrophic scar score. Timepoint: 2nd, 12th and 24th weeks after surgery. Method of measurement: Vancouver scar scale(VSS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSadra Ashrafi

Shahid Beheshti University of Medical Sciences

sadra.ashrafi@sbmu.ac.ir+98 21 23871

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026